MEDIUM confidence
Researched 2026-07-22 22:52 · profile: researcher
Programme Thesis
This program funds collaborative projects between U.S. and Algerian entities that advance innovation, commerce, and English language proficiency. It exists to strengthen bilateral ties and foster economic development through joint research, entrepreneurship, and capacity-building initiatives.
Selection Criteria
- Relevance to program goals: U.S.-Algerian collaboration, innovation, commerce, or English language
- Clear partnership structure with at least one U.S. and one Algerian organization
- Feasibility and sustainability of proposed activities
- Potential for measurable impact on economic or educational outcomes
- Qualifications and track record of key personnel
- Budget justification and cost-effectiveness
- Letters of support from partner institutions
Past Winners / Cohort Profiles
No specific past winners are listed on the program page. Typical awardees include U.S.-Algerian university partnerships, NGOs, and small businesses working on technology transfer, entrepreneurship training, or English-language education. Profiles often feature joint research teams, exchange programs, or curriculum development projects.
Ideal Candidate Fingerprint
A collaborative team with a U.S.-based institution and an Algerian partner (university, research center, or company) proposing a concrete project in innovation (e.g., tech commercialization, health tech) or commerce (e.g., market access, trade facilitation). The lead PI should have a strong publication record, prior cross-border collaboration experience, and a clear plan for sustaining outcomes beyond the grant period.
Recommended Framing
Eniola should position his CCT model and platforms (IMPRINT, TOPOLOGIX) as a U.S.-Algerian collaborative innovation in computational neuroscience and addiction pharmacology. He can propose a joint research initiative with an Algerian university (e.g., University of Algiers) to adapt his Bayesian-validated framework for local substance abuse patterns, leveraging his provisional patent and endorsements from U.S. neuroscientists (Berridge, Gershman) to demonstrate translational potential and commercial viability. Emphasize the LMIC angle: Algeria faces rising addiction rates, and his low-cost, open-source tools (Apache 2.0) align with the program's innovation and public health goals.
Watch Out
Eniola is an independent researcher without a formal institutional affiliation in the U.S. or Algeria, which may complicate the required partnership structure. He is not yet enrolled in a PhD program, and his age (29) and pre-PhD status may be seen as less competitive for a grant targeting established researchers. The program's focus on commerce and English language may not perfectly align with his pure neuroscience/pharmacology research, requiring careful framing toward health innovation and capacity building.